Should I buy Docusign (DOCU) stock or is it too late?
⭐ The most reliable of them, either direction: Baird — 68% of its targets hit on this sector (91 calls tested). It aims for $72 (-0.4 %), call made on September 5, 2026, maturing on September 5, 2027 (39 d ago).
Firm-by-firm track record on Docusign
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wedbush | 69 % | +63.1 % | 13 | $58 -20% |
| RBC Capital | 50 % | +48.5 % | 12 | $70 -3% |
| JP Morgan | 71 % | +37.5 % | 7 | $65 -10% |
| JMP Securities | 50 % | +13.8 % | 32 | $124 +71% |
| Citigroup | 44 % | +6.1 % | 25 | $72 +0% |
| Morgan Stanley | 42 % | +1.3 % | 12 | $75 +4% |
| Wells Fargo | 50 % | -8.0 % | 8 | $60 -17% |
| UBS | 57 % | -12.3 % | 7 | $70 -3% |
✅ Reasons to believe
- Few solid positives from analysts right now: of 13 ratings, only 2 buys, and the median price target ($71) is -2% below the price ($72). Caution prevails.
⚠️ Reasons to hesitate
- Even the most reliable firm on DOCU, JP Morgan (71% hit rate, 7 scored calls), only targets $65 (call made on March 18, 2026, maturing on March 18, 2027) (-10%) in its most recent call, and $78 (call made on December 5, 2025, maturing on December 5, 2026) (+8%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 13 ratings, 10 are neutral and 1 is a sell.
- Limited upside: the median target is only -2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on DOCU
Median target $71 (-2%) · 13 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Docusign now?
We won't decide for you. The facts: 15% of analysts rate it a buy, median target $71 (-2%), and JP Morgan (most reliable on DOCU, 71%) targets $65. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Docusign?
The stated upside is small: the median target ($71) sits just -2% from the price ($72) (most reliable on DOCU: JP Morgan, 71%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Docusign still worth investing in?
It depends on the gap between the price ($72) and its estimated value: analysts target $71 on median (-2%), with 15% buys (most reliable on DOCU: JP Morgan, 71%). Cross-check with their real reliability on DOCU and the cautions above. Information, not advice.
What's the main risk in buying DOCU?
Even the most reliable firm on DOCU, JP Morgan (71% hit rate, 7 scored calls), only targets $65 (call made on March 18, 2026, maturing on March 18, 2027) (-10%) in its most recent call, and $78 (call made on December 5, 2025, maturing on December 5, 2026) (+8%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Docusign profile (consensus, analyst reliability, price target, performance).